
Insider and congress filings
Boston Scientific Corporation (BSX)
NYSE · Healthcare · 304 insider filings · 171 congress trades · last filed 7 days agoS&P 500
About Boston Scientific Corporation
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Michael F. Mahoney
- Employees
- 59,000
- Listed since
- May 19, 1992
- Market value
- $66.8B
- Price to earnings
- 18.1
- Earnings per share
- $2.48
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 28, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 29, 2026 | $0.86 | $0.83 | $5.4B | $5.4B | EPS beatRevenue in line |
| Apr 22, 2026 | $0.80 | $0.79 | $5.2B | $5.2B | EPS beatRevenue in line |
| Feb 4, 2026 | $0.80 | $0.78 | $5.3B | $5.3B | EPS beatRevenue in line |
| Oct 22, 2025 | $0.75 | $0.71 | $5.1B | $5.0B | EPS beatRevenue beat |
| Q2 FY2025reported Jul 23, 2025 | $0.75 | $0.72 | $5.1B | $4.9B | EPS beatRevenue beat |
| Q1 FY2025reported Apr 23, 2025 | $0.75 | $0.67 | $4.7B | $4.6B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 18, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Michael F. MahoneyChairman of the Board, President and Chief Executive O | $1.4M | $13.6M | $8.5M | $23.5M |
| Joseph M. FitzgeraldExecutive Vice President and Group President, Cardiova | $893K | $4.3M | $2.8M | $8.0M |
| Arthur C. ButcherExecutive Vice President and Group President, MedSurg | $745K | $3.4M | $2.3M | $6.5M |
| Jonathan R. MonsonExecutive Vice President and Chief Financial Officer | $592K | $1.6M | $3.9M | $6.1M |
| Jeffrey B. MirvissExecutive Vice President and President, Peripheral Int | $702K | $2.0M | $1.5M | $4.2M |
| Vance R. BrownSenior Vice President, General Counsel and Corporate S | $659K | $1.7M | $1.5M | $3.9M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $5.5B | 129,680,916 | -1.6% | 8.78% |
| Vanguard Capital Management LLC | $4.1B | 97,087,553 | +0.7% | 6.57% |
| State Street Corp | $3.0B | 70,111,196 | +3.1% | 4.74% |
| Primecap Management Co | $2.2B | 50,520,914 | +55.3% | 3.42% |
| FMR LLC | $2.0B | 45,702,845 | -38.4% | 3.09% |
| Massachusetts Financial Services Co | $1.5B | 24,859,191 | +126.1% | 1.68% |
| Geode Capital Management, LLC | $1.4B | 33,440,102 | +0.5% | 2.26% |
| Vanguard Portfolio Management LLC | $1.3B | 29,792,794 | -0.0% | 2.02% |
| D. E. Shaw & Co., Inc. | $1.1B | 25,457,409 | +4.7% | 1.72% |
| Jpmorgan Chase & Co | $1.0B | 23,907,838 | -28.3% | 1.62% |
| Arrowstreet Capital, Limited Partnership | $994.2M | 23,293,913 | +67.7% | 1.58% |
| Norges Bank | $903.5M | 21,170,029 | +100.0% | 1.43% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Open-market insider trades
10 filings of 304 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Susan E. MoranoDirector | Bought | 2,040 | $49.22 | $100K | Aug 25, 2026 | 1d |
| David C. HabigerDirector | Bought | 2,100 | $47.59 | $100K | Aug 5, 2026 | 2d |
| David C. HabigerDirector | Bought | 140 | $48.59 | $7K | Aug 4, 2026 | 1d |
| David C. HabigerDirector | Bought | 1,042 | $48.07 | $50K | Aug 3, 2026 | 2d |
| Michael F. MahoneyChairman, President & CEO | Bought | 186,240 | $48.33 | $9.0M | Aug 3, 2026 | 2d |
| Edward J. LudwigDirector | Bought | 5,000 | $45.48 | $227K | Jul 31, 2026 | 3d |
| Cheryl PegusDirector | Bought | 1,770 | $56.49 | $100K | May 20, 2026 | 1d |
| Edward J. LudwigDirector | Bought | 3,580 | $56.68 | $203K | May 20, 2026 | 1d |
| David C. HabigerDirector | Bought | 2,250 | $55.92 | $126K | May 20, 2026 | 1d |
| David C. HabigerDirector | Bought | 2,200 | $56.95 | $125K | May 19, 2026 | 2d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in BSX
20 disclosures of 171 on record · median 27d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -7.2%S&P +0.6% · vs S&P 500 -7.8% | Aug 3, 2026 | Sep 4, 2026 | 32d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -10.9%S&P -1.4% · vs S&P 500 -9.5% | Aug 10, 2026 | Sep 4, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +2.7%S&P +2.7% · vs S&P 500 0.0% | Jul 20, 2026 | Aug 7, 2026 | 18d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -0.7%S&P +2.0% · vs S&P 500 -2.8% | Jul 7, 2026 | Aug 7, 2026 | 31d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | -35.0%S&P +20.2% · vs S&P 500 -55.2% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| John BoozmanJoint | Stock | Sale (Partial) | $1,001 - $15,000 | -8.0%S&P +0.7% · vs S&P 500 -8.6% | Jun 4, 2026 | Jul 13, 2026 | 39d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -4.2%S&P +1.6% · vs S&P 500 -5.8% | Jun 16, 2026 | Jul 6, 2026 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -5.7%S&P +0.4% · vs S&P 500 -6.1% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +5.3%S&P +2.1% · vs S&P 500 +3.3% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -7.4%S&P +3.4% · vs S&P 500 -10.8% | Jun 5, 2026 | Jul 2, 2026 | 27d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -7.4%S&P +3.4% · vs S&P 500 -10.8% | Jun 5, 2026 | Jul 2, 2026 | 27d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -14.6%S&P +3.2% · vs S&P 500 -17.8% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | -20.4%S&P +5.8% · vs S&P 500 -26.2% | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -10.9%S&P +1.6% · vs S&P 500 -12.5% | May 27, 2026 | Jun 9, 2026 | 13d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -20.9%S&P +3.9% · vs S&P 500 -24.7% | May 19, 2026 | Jun 8, 2026 | 20d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -15.8%S&P +3.1% · vs S&P 500 -18.9% | May 11, 2026 | Jun 8, 2026 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -6.9%S&P +0.8% · vs S&P 500 -7.7% | May 29, 2026 | Jun 8, 2026 | 10d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -27.6%S&P +6.8% · vs S&P 500 -34.3% | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -28.8%S&P +11.6% · vs S&P 500 -40.4% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | -28.6%S&P +20.7% · vs S&P 500 -49.2% | Mar 30, 2026 | Apr 7, 2026 | 8d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
8 members · estimate, as of Sep 10, 20268 members report a position (estimated). The largest estimated position is in the $250,001 - $500,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Kevin Hern | Republican · House | $250,001 - $500,000 | 0.9% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $100,001 - $250,000 | 0.3% |
| Markwayne Mullin | Republican · Senate | $50,001 - $100,000 | 0.2% |
| Julie Johnson | Democrat · House | $15,001 - $50,000 | 0.1% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.1% |
| Tina Smith | Democrat · Senate | $1,001 - $15,000 | 0.2% |
| Harriet M. Hageman | Republican · House | $1,001 - $15,000 | 0.1% |
| Michael A. Rulli | Republican · House | $1,001 - $15,000 | 0.4% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Padraig Andrew O'ConnorEVP, Global Operations | Option exercise | 1,171 | Sep 2, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Tax withholding | 567 | Sep 2, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Discretionary transaction | 2,930 | Aug 11, 2026 |
| Jonathan MonsonEVP and CFO | Discretionary transaction | 9,908 | Aug 10, 2026 |
| Michael F. MahoneyChairman, President & CEO | Discretionary transaction | 22,119 | Aug 3, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Discretionary transaction | 64,198 | Jul 31, 2026 |
| Jonathan MonsonEVP and CFO | Option exercise | 2,087 | Jul 1, 2026 |
| Jonathan MonsonEVP and CFO | Tax withholding | 1,010 | Jul 1, 2026 |
| Michael F. MahoneyChairman, President & CEO | Gift | 386,755 | May 28, 2026 |
| Ellen M. ZaneDirector | Stock award | 3,800 | May 7, 2026 |
| David S. WichmannDirector | Stock award | 3,800 | May 7, 2026 |
| Christophe Pierre WeberDirector | Stock award | 5,567 | May 7, 2026 |
| Cathy R. SmithDirector | Stock award | 6,009 | May 7, 2026 |
| Cheryl PegusDirector | Stock award | 5,081 | May 7, 2026 |
| Susan E. MoranoDirector | Stock award | 5,081 | May 7, 2026 |
| Jessica L. MegaDirector | Stock award | 3,800 | May 7, 2026 |
| Edward J. LudwigDirector | Stock award | 3,800 | May 7, 2026 |
| David C. HabigerDirector | Stock award | 3,800 | May 7, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Option exercise | 1,802 | May 2, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Tax withholding | 872 | May 2, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling BSX?
Across the 10 most recent open-market filings shown here, 10 were purchases and 0 were sales.
Which members of Congress have traded BSX?
Ro Khanna, Alan Armstrong, John Boozman, Gilbert Ray Cisneros, Jr. disclosed BSX transactions in the filings shown here.
Which members of Congress hold BSX?
8 members of Congress report a position in BSX in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Kevin Hern, Gilbert Ray Cisneros, Jr. and Markwayne Mullin. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is BSX in the S&P 500 or the Nasdaq 100?
Boston Scientific Corporation is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are BSX trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
